首页 | 本学科首页   官方微博 | 高级检索  
     


Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain.
Authors:J R Proudfoot  R Betageri  M Cardozo  T A Gilmore  S Glynn  E R Hickey  S Jakes  A Kabcenell  T M Kirrane  A K Tibolla  S Lukas  U R Patel  R Sharma  M Yazdanian  N Moss  P L Beaulieu  D R Cameron  J M Ferland  J Gauthier  J Gillard  V Gorys  M Poirier  J Rancourt  D Wernic  M Llinas-Brunet
Affiliation:Boehringer Ingelheim (Canada) Ltd., Research and Development, 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada. jproudfo@rdg.boehringer-ingelheim.com
Abstract:
p56lck is a member of the src family of tyrosine kinases and plays a critical role in the signal transduction events that lead to T cell activation. Ligands for the p56lck SH2 domain have the potential to disrupt the interaction of p56lck with its substrates and derail the signaling cascade that leads to the production of cytokines such as interleukin-2. Starting from the quintuply charged (at physiological pH) phosphorylated tetrapeptide, AcpYEEI, we recently disclosed (J. Med. Chem. 1999, 42, 722 and J. Med. Chem. 1999, 42, 1757) the design of the modified dipeptide 3, which carries just two charges at physiological pH. Here we present the elaboration of 3 to the nonpeptidic, monocharged compound, 9S. This molecule displays good binding affinity for the p56lck SH2 domain (K(d) 1 microM) and good cell permeation, and this combination of properties allowed us to demonstrate clear-cut inhibitory effects on a very early event in T cell activation, namely calcium mobilization.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号